Restricted accessResearch articleFirst published online 2014-11
The Use of Exchange-Free Periods Alternating with Daily Exchanges of Icodextrin in the Initial Treatment of Peritoneal Dialysis-Associated Peritonitis: A Safety Study
AlobaidiH.M., ColesG.A., DaviesM., LioydD.Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function.Nephrol Dial Transplant1986; 1: 16–21.
2.
KeaneW.F., ComtyC.M., VerburghH.A., PetersonP.K.Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.Kidney Int1984; 25: 539–43.
3.
GovindarajuluS., HawleyC.M., MacdonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases.Perit Dial Int2010: 30(3): 311–9.
4.
GhaliJ.R., BannisterK.M., BrownF.G., RosmanJ.B., WigginsK.J., JohnsonD.W.Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients.Perit Dial Int2011; 31: 651–62.
5.
ParikovaA., ZweersM.M., StrujikD.G., KredietR.T.Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions.Adv Perit Dial2003; 19: 186–90.
6.
OpatrnaS., LysakD., TrefilL., ParkerC., TopleyN.Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions.Perit Dial Int2012; 32: 37–44.
